We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay

News   Jun 11, 2015

 
Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay
 
 
 

RELATED ARTICLES

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

World Trade Center Responders at Increased Risk of Head and Neck Cancers

News

The study, which is the first to report on head and neck cancers in World Trade Center first responders, found a 40 percent increase in diagnosis of these diseases between 2009 and 2012.

READ MORE

Tuberculosis Tests are Inadequate, Better Options Identified

News

Rapid blood tests used by the NHS are unable to rule out tuberculosis (TB) and should be replaced with a new, more accurate test, a study has found.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE